CytoDyn Inc. Gain (Loss) on Sale of Derivatives
CytoDyn Inc. (CYDY) reported Gain (Loss) on Sale of Derivatives of $0 for the 12-month period ending 2026-05-31, per its 10-K filed 2026-08-31.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnSaleOfDerivatives · last filed 2026-08-31
- CytoDyn Inc. gain (loss) on sale of derivatives for the quarter ending 2025-05-31 was $0.00, a 100.00% decline year-over-year.
- CytoDyn Inc. gain (loss) on sale of derivatives for the quarter ending 2025-02-28 was $0.00.
- CytoDyn Inc. gain (loss) on sale of derivatives for the quarter ending 2024-11-30 was $0.00.
- CytoDyn Inc. gain (loss) on sale of derivatives for the quarter ending 2024-08-31 was -$852.00K, a 21400.00% decline year-over-year.
- CytoDyn Inc. gain (loss) on sale of derivatives for fiscal 2026 was $0.00.
- CytoDyn Inc. gain (loss) on sale of derivatives for fiscal 2025 was -$852.00K.
- CytoDyn Inc. gain (loss) on sale of derivatives for fiscal 2023 was -$8.75M.
| Period end | Gain (Loss) on Sale of Derivatives 3 month | Gain (Loss) on Sale of Derivatives 6 month | Gain (Loss) on Sale of Derivatives 9 month | Gain (Loss) on Sale of Derivatives 12 month |
|---|---|---|---|---|
| 2026-05-31 | $0.00 10-K · filed 2026-08-31 | |||
| 2025-05-31 | $0.00 derived: 10-K 12 month − S-1 9 month · filed 2026-08-31 | $0.00 derived: sum of 2 quarters · filed 2026-08-31 | $0.00 derived: sum of 3 quarters · filed 2026-08-31 | -$852.00K 10-K · filed 2026-08-31 |
| 2025-02-28 | $0.00 derived: S-1 9 month − 10-Q 6 month · filed 2026-04-22 | $0.00 derived: sum of 2 quarters · filed 2026-04-22 | -$852.00K S-1 · filed 2026-04-22 | -$117.00K derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-01-09 | -$852.00K 10-Q · filed 2026-01-09 | -$117.00K derived: sum of 3 quarters · filed 2026-04-22 | -$1.07M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-08-31 | -$852.00K 10-Q · filed 2025-10-10 | -$117.00K derived: sum of 2 quarters · filed 2026-04-22 | -$1.07M derived: sum of 3 quarters · filed 2026-04-22 | -$1.09M derived: sum of 4 quarters · filed 2026-04-22 |
| 2024-05-31 | $735.00K derived: S-1 12 month − 10-Q 9 month · filed 2026-04-22 | -$223.00K derived: sum of 2 quarters · filed 2026-04-22 | -$240.00K derived: sum of 3 quarters · filed 2026-04-22 | -$236.00K S-1 · filed 2026-04-22 |
| 2024-02-29 | -$958.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-04-14 | -$975.00K derived: sum of 2 quarters · filed 2025-04-14 | -$971.00K 10-Q · filed 2025-04-14 | -$965.00K derived: sum of 4 quarters · filed 2025-04-14 |
| 2023-11-30 | -$17.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-01-14 | -$13.00K 10-Q · filed 2025-01-14 | -$7.00K derived: sum of 3 quarters · filed 2025-01-14 | -$162.00K derived: sum of 4 quarters · filed 2025-01-14 |
| 2023-08-31 | $4.00K 10-Q · filed 2024-10-15 | $10.00K derived: sum of 2 quarters · filed 2024-10-15 | -$145.00K derived: sum of 3 quarters · filed 2024-10-15 | -$145.00K derived: sum of 4 quarters · filed 2024-10-15 |
| 2023-05-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-15 | -$149.00K derived: sum of 2 quarters · filed 2024-08-15 | -$149.00K derived: sum of 3 quarters · filed 2024-08-15 | -$8.75M 10-K · filed 2024-08-15 |
| 2023-02-28 | -$155.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-04-15 | -$155.00K derived: sum of 2 quarters · filed 2024-04-15 | -$8.76M 10-Q · filed 2024-04-15 | |
| 2022-11-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-01-16 | -$8.60M 10-Q · filed 2024-01-16 | ||
| 2022-08-31 | -$8.60M 10-Q · filed 2023-10-23 |